Just - Evotec Biologics
Jennifer Smith-Yuen has a strong background in project and alliance management within the biotechnology and pharmaceutical industry. She has experience working with various organizations such as Amgen, Bill & Melinda Gates Foundation, and Just - Evotec Biologics. Jennifer's expertise lies in overseeing global biotherapeutics projects and ensuring robust implementation plans are in place for new interventions. Jennifer holds a BS in Biology and has a solid foundation in research and development project management.
Just - Evotec Biologics
1 followers
Just – Evotec Biologics, wholly owned by Evotec SE, is a first-to-industry biologics platform that leverages AI/ML technologies and world-leading molecular design, cell line development, process intensification and continuous manufacturing strategies to advance biotherapeutics from discovery through clinical stages to commercial launch. The Just – Evotec Biologics team combines deep industry experience in the fields of data, protein, process, and manufacturing sciences including automation with highly integrated and flexible capabilities to break through the scientific and economic barriers associated with the development of protein therapeutics. Our focus is to accelerate and expand access to biotherapeutics through scientific and technological innovation for our proprietary projects and on behalf of our partners. Learn more at www.just-evotecbiologics.com